References
- Smorodintsev A, Nasibov M, Jakovleva N. Experience with live rubella virus vaccine combined with live vaccines against measles and mumps. Bull. WHO. 1970;42:283.
- Beck M, Welsz-Malecek R, Mesko-Prejac M, et al. Mumps vaccine L-Zagreb, prepared in chick fibroblasts. I. Production and field trials. J. Biol. Stand. 1989;17:85–90.10.1016/0092-1157(89)90031-0
- Jefferson T, Price D, Demicheli V, et al. Unintended events following immunization with MMR: a systematic review. Vaccine. 2003;21:3954–3960.10.1016/S0264-410X(03)00271-8
- Park T, Ki M, Yi SG. Statistical analysis of MMR vaccine adverse events on aseptic meningitis using the case cross-over design. Stat. Med. 2004;23:1871–1883.10.1002/(ISSN)1097-0258
- Rezaei M, Mamishi S, Mahmoudi S, et al. Cerebrospinal fluid ferritin in children with viral and bacterial meningitis. Br. J. Biomed. Sci. 2013;70:101–103.
- Pourakbari B, Mahmoudi S, Movahedi Z, et al. Viral etiology of acute lower respiratory tract infections in hospitalized young children in a children’s referral hospital in Iran. Turk. J. pediatr. 2014;56:354–359.
- Poggio GP, Rodriguez C, Cisterna D, et al. Nested PCR for rapid detection of mumps virus in cerebrospinal fluid from patients with neurological diseases. J. clin. microbiol. 2000;38:274–278.
- Galazka A, Robertson S, Kraigher A. Mumps and mumps vaccine: a global review. Bull. WHO. 1999;77:3.
- Brown EG, Dimock K, Wright KE. The Urabe AM9 mumps vaccine is a mixture of viruses differing at amino acid 335 of the hemagglutinin-neuraminidase gene with one form associated with disease. J. Infect. Dis. 1996;174:619–622.10.1093/infdis/174.3.619
- Farrington P, Rush M, Miller E, et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet. 1995;345:567–569.10.1016/S0140-6736(95)90471-9
- Barlow WE, Davis RL, Glasser JW, et al. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N. Engl. J. Med. 2001;345:656–661.10.1056/NEJMoa003077
- da Silveira CM, Kmetzsch CI, Mohrdieck R, et al. The risk of aseptic meningitis associated with the Leningrad-Zagreb mumps vaccine strain following mass vaccination with measles-mumps-rubella vaccine, rio grande do sul, brazil, 1997. Int. J. Epidemiol. 2002;31:978–982.10.1093/ije/31.5.978
- Atrasheuskaya A, Kulak M, Fisenko EG, et al. Horizontal transmission of the Leningrad–Zagreb mumps vaccine strain: A report of six symptomatic cases of parotitis and one case of meningitis. Vaccine. 2012;30:5324–5326.10.1016/j.vaccine.2012.06.055
- Tešović G, Poljak M, Lunar MM, et al. Horizontal transmission of the Leningrad–Zagreb mumps vaccine strain: A report of three cases. Vaccine. 2008;26:1922–1925.10.1016/j.vaccine.2008.02.014
- da Cunha SS, Rodrigues LC, Barreto ML, et al. On “No definitive evidence for L-Zagreb mumps strain associated aseptic meningitis: a review with special reference to the da Cunha study”, Vaccine 2005;23:5286–8, by Kulkarni PS, et al. Vaccine. 2006;24:4261–4262.10.1016/j.vaccine.2005.12.014
- Kulkarni PS, Phadke MA, Jadhav SS, et al. No definitive evidence for L-Zagreb mumps strain associated aseptic meningitis: a review with special reference to the da Cunha study. Vaccine. 2005;23:5286–5288.10.1016/j.vaccine.2005.05.029
- Fujinaga T, Motegi Y, Tamura H, et al. A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine. Pediatr. Infect. Dis. J. 1991;10:204–208.10.1097/00006454-199103000-00007
- Al-Mazrou Y, Tumsah S, Khalil M, et al. Safety evaluation of MMR Vaccine during a primary school campaign in Saudi Arabia. J. Trop. Pediatr. 2002;48:354–358.10.1093/tropej/48.6.354
- Cizman M, Mozetic M, Radescek-Rakar R, et al. Aseptic meningitis after vaccination against measles and mumps. Pediatr. Infect. Dis. J. 1989;8:302–308.